Hubei Biocause Pharmaceutical Co., Ltd Environmental Analytics
Environmental and financial analysis dashboard for Hubei Biocause Pharmaceutical Co., Ltd. Industry: FINANCIAL AND INSURANCE ACTIVITIES
Company Overview for Hubei Biocause Pharmaceutical Co., Ltd
Highlights
Showing data for FY2022
Operational Environmental Cost
$2.13m
Operational Environmental Cost Intensity
0.03%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$-0.03m
Decoupling Rate (2020-2022)
8.01%
Adjusted EBITDA
$4,474m
Adjusted EBITDA Margin
63%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 16.46% | -10.49% | N/A | ||
| 0.00% | 0.00% | 0.00% | N/A | |
| 13.86% | -14.39% | N/A | ||
| 0.03% | 0.03% | 0.03% | N/A | |
| $2m | $2m | $2m | N/A | |
| 14.22% | -13.84% | N/A | ||
| 0.04% | 0.03% | 0.03% | N/A | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
63%
Adjusted EBIT Margin
62%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$6,129m | $7,770m | $7,128m | $6,966m | |
| 26.78% | -8.26% | -2.28% | ||
$5,585m | $2,758m | $2,652m | $3,900m | |
| 91.13% | 35.50% | 37.21% | 55.99% | |
$544m | $5,012m | $4,476m | $3,066m | |
| 8.87% | 64.50% | 62.79% | 44.01% | |
$532m | $4,989m | $4,453m | $3,043m | |
| 8.68% | 64.20% | 62.48% | 43.68% | |
| ENVIRONMENTAL COST DATA | ||||
$2m | $2m | $2m | N/A | |
| 0.04% | 0.03% | 0.03% | 0.00% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$541m | $5,009m | $4,474m | N/A | |
| 8.84% | 64.47% | 62.76% | 0.00% | |
$530m | $4,986m | $4,451m | N/A | |
| 8.64% | 64.17% | 62.45% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
INSURANCE
Scope 1 (% of Sales)
0.00%
Scope 2 (% of Sales)
0.03%
Operational Environmental Cost Intensity
0.03%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Hubei Biocause Pharmaceutical Co., Ltd | N/A | $2m | 0.03% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022